ACCRETAMAB - Trademark Details
Status: 800 - Registered And Renewed
Serial Number
77178675
Registration Number
3653037
Word Mark
ACCRETAMAB
Status
800 - Registered And Renewed
Status Date
2019-04-10
Filing Date
2007-05-11
Registration Number
3653037
Registration Date
2009-07-14
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2009-04-28
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
FAHRENKOPF, PAUL E
Statements
Goods and Services
[Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases]
Goods and Services
Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of host cells; contract extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of host cells; technical consultation in the field of manufacturing technology in the field of host cells; providing technical information in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals technical consultation in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals
Goods and Services
Development of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
B - Sec. 8 - Class(es) in a Multiple Class registration -- Partial Cancellation
Class Status Date
2015-08-05
Primary Code
005
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2007-05-16
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2007-05-16
Primary Code
042
Current Trademark Owners
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
31 - 1st New Owner Entered After Registration
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
11 - 1st New Owner Before Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Kaushal R. Odedra
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
2007-04-25 | 2007041644 | Japan | True |
Trademark Events
Event Date | Event Description |
2007-05-16 | NEW APPLICATION ENTERED IN TRAM |
2007-08-24 | ASSIGNED TO EXAMINER |
2007-08-24 | SUSPENSION LETTER WRITTEN |
2007-08-24 | LETTER OF SUSPENSION MAILED |
2008-02-24 | ASSIGNED TO LIE |
2008-02-24 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
2008-03-25 | SUSPENSION INQUIRY WRITTEN |
2008-03-26 | INQUIRY AS TO SUSPENSION MAILED |
2008-06-09 | PAPER RECEIVED |
2008-06-10 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2008-06-10 | AMENDMENT FROM APPLICANT ENTERED |
2008-06-11 | SUSPENSION LETTER WRITTEN |
2008-06-11 | LETTER OF SUSPENSION MAILED |
2008-11-19 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
2008-12-11 | LIE CHECKED SUSP - TO ATTY FOR ACTION |
2009-01-11 | SUSPENSION INQUIRY WRITTEN |
2009-01-12 | INQUIRY AS TO SUSPENSION MAILED |
2009-02-06 | PAPER RECEIVED |
2009-02-09 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2009-02-09 | AMENDMENT FROM APPLICANT ENTERED |
2009-02-09 | SUSPENSION INQUIRY WRITTEN |
2009-02-10 | INQUIRY AS TO SUSPENSION MAILED |
2009-02-23 | PAPER RECEIVED |
2009-02-24 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2009-02-24 | AMENDMENT FROM APPLICANT ENTERED |
2009-03-23 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2009-03-23 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2009-04-08 | NOTICE OF PUBLICATION |
2009-04-28 | PUBLISHED FOR OPPOSITION |
2009-07-14 | REGISTERED-PRINCIPAL REGISTER |
2015-07-01 | TEAS SECTION 8 RECEIVED |
2015-08-05 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
2015-08-05 | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED |
2015-08-05 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED |
2018-07-14 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED |
2019-04-08 | TEAS SECTION 8 & 9 RECEIVED |
2019-04-10 | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED |
2019-04-10 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) |
2019-04-10 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED |
2019-09-04 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |